CLPT · ClearPoint Neuro, Inc.
Market Cap
$460.00M
Shares
30.50M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$36.97M
+17.8%
FY2025
Net Income
-$25.54M
-35%
FY2025
Gross Margin
61.38%
+0.5pp
FY2025
Operating Margin
-65.36%
-2.5pp
FY2025
Diluted EPS
-$0.90
-28.6%
FY2025
Operating Cash Flow
-$23.9M
-167%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $42.28M | $36.97M | $31.39M | $23.96M | $20.55M | $16.3M | $12.83M | $11.22M | $7.35M | $7.38M | $5.75M | $4.59M | $3.6M | $3.93M | $5.06M | $3.82M | $2.67M | |
| -$246K | — | $872K | $386K | -$81K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $15.81M | $14.28M | $12.27M | $10.34M | $7.02M | $5.18M | $3.71M | $3.94M | $2.43M | $2.9M | $2.64M | $1.99M | $1.93M | $1.42M | $555.7K | $656.41K | $16.31K | |
| $26.47M | $22.69M | $19.12M | $13.61M | $13.53M | $11.12M | $9.12M | — | — | — | — | — | — | — | — | — | — | |
| — | 61.38% | 60.92% | 56.83% | 65.84% | 68.24% | 71.09% | — | — | — | — | — | — | — | — | — | — | |
| $15.84M | $13.9M | $12.39M | $11.71M | $10.89M | $9.28M | $4.69M | $2.81M | $2.31M | $2.81M | $2.63M | $1.96M | $3.3M | $2.92M | $2.48M | $4.25M | $5.68M | |
| $22.09M | $16.46M | $14.48M | $12.6M | $9.36M | $7.22M | $5.38M | $4.76M | $3.53M | $3.96M | $3.78M | — | — | — | — | — | — | |
| $19.58M | $16.5M | $11.99M | $11.76M | $9.61M | $8M | $5.27M | $4.3M | $4.33M | $4.05M | $4.19M | $8.37M | $8.04M | $7.06M | $6.03M | $4.83M | $4.7M | |
| — | $168K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $551K | $814K | $980K | $626K | $244K | $159K | $334K | $144K | $109.44K | $116.45K | $155.71K | $211.95K | $377.26K | $426.18K | $416.97K | $354.89K | $266.22K | |
| — | — | — | — | — | — | — | — | — | — | — | $1.25M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $11.41M | $8.19M | $9.74M | $12.18M | |
| -$31.04M | -$24.16M | -$19.73M | -$22.45M | -$16.33M | -$13.37M | -$6.22M | -$4.59M | -$5.25M | -$6.34M | -$7.49M | -$8.97M | -$5.32M | -$7.47M | -$3.13M | -$5.92M | -$9.52M | |
| — | -65.36% | -62.87% | -93.7% | -79.47% | -82.05% | -48.48% | -40.96% | -71.37% | -85.86% | -130.25% | -195.34% | -147.61% | -190.17% | -61.87% | -155.09% | -356.45% | |
| -$30.49M | -$23.35M | -$18.75M | -$21.82M | -$16.09M | -$13.22M | -$5.89M | -$4.45M | -$5.14M | -$6.22M | -$7.33M | -$8.76M | -$4.94M | -$7.05M | -$2.71M | -$5.57M | -$9.25M | |
| — | $2.39M | $518K | — | $81K | $973K | $1.44M | $955K | $980.38K | $872.93K | $1.05M | $1.26M | $1.02M | $499.84K | $2.59M | $2.5M | $1.59M | |
| — | $1.21M | $1.39M | — | — | — | — | — | — | — | $8807 | $16.46K | $11.62K | $24.54K | $14.15K | $3481 | $10.4K | |
| -$140K | -$146K | -$40K | -$29K | -$22K | -$63K | $882K | $9000 | $364 | $16.68K | $216.08K | $230.88K | $175.55K | $56.23K | $3586 | $104.85K | $413.62K | |
| -$34.58M | -$25.49M | -$18.9M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$18K | $55K | $12K | $8000 | $0 | $0 | $0 | — | — | — | — | — | $0 | $0 | $0 | — | — | |
| -$34.57M | -$25.54M | -$18.91M | -$22.09M | -$16.44M | -$14.41M | -$6.78M | -$5.54M | -$6.16M | -$7.17M | -$8.07M | -$8.45M | -$4.52M | -$7.09M | -$5.88M | -$8.31M | -$9.45M | |
| — | -69.08% | -60.25% | -92.21% | -79.97% | -88.41% | -52.86% | -49.39% | -83.82% | -97.12% | -140.36% | -183.91% | -125.53% | -180.29% | -116.2% | -217.68% | -354.16% | |
| USD/shares | -$1.17 | -$0.90 | -$0.70 | -$0.90 | -$0.68 | -$0.69 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$1.17 | -$0.90 | -$0.70 | -$0.90 | -$0.68 | -$0.69 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M | 15.85M | 13.16M | 10.93M | 7.74M | 2.75M | 1.88M | 59.24M | 57.26M | 40.37M | 15.96M | 6.77M |
| shares | — | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M | 15.85M | 13.16M | 10.93M | 7.74M | 2.75M | 1.88M | 59.24M | 57.26M | 40.37M | 15.96M | 6.77M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
11.37×
Peer median 2.40×
EV/EBIT
—
Peer median 23.80×
P/E (TTM)
—
Peer median 24.50×
Peer medians compare against the 76 similar-size Medical Devices companies (of 144 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Product | $23,859,000 | $18,626,000 | $10,603,000 | $12,789,000 | $11,913,000 | $8,832,000 |
| Biologics and Drug Delivery | $19,040,000 | $17,310,000 | $13,602,000 | $9,120,000 | $6,795,000 | $5,200,000 |
| Neurosurgery Navigation and Therapy Disposable Products | $14,831,000 | $10,285,000 | — | — | — | — |
| Neurosurgery Navigation and Therapy | $14,831,000 | $10,285,000 | $8,520,000 | — | — | — |
| Service | $13,112,000 | $12,764,000 | $13,352,000 | $7,762,000 | $4,386,000 | $3,997,000 |
| Biologics and Drug Delivery Services and License Fees | $11,702,000 | $11,704,000 | $11,448,000 | $5,430,000 | $3,442,000 | — |
| Biologics and Drug Delivery Disposable Products | $7,338,000 | $5,606,000 | $2,154,000 | $3,690,000 | $3,353,000 | $1,528,000 |
| Capital Equipment and Software | $3,100,000 | $3,795,000 | $1,833,000 | $2,307,000 | $1,433,000 | $1,418,000 |
| Capital Equipment and Software Related Service | $2,100,000 | $2,300,000 | — | — | — | — |
| Capital Equipment and Software Systems and Software Products | $1,690,000 | $2,735,000 | $860,000 | $1,512,000 | $864,000 | $1,093,000 |
| Capital Equipment and Software Services | $1,410,000 | $1,060,000 | $973,000 | $795,000 | $569,000 | $325,000 |
| Biologics and Drug Delivery Services | — | — | — | — | $3,442,000 | $3,672,000 |
| Capital Equipment Related Service Revenue | — | $2,300,000 | $1,100,000 | — | — | — |
| Functional Neurosurgery Navigation And Therapy Disposable Products | — | — | $7,589,000 | $7,587,000 | — | — |
| Functional Neurosurgery Navigation and Therapy | — | — | $8,520,000 | $9,124,000 | $8,071,000 | $6,211,000 |
| Functional Neurosurgery Navigation and Therapy Services | — | — | $931,000 | $1,537,000 | — | — |
| Neurosurgery Navigation and Therapy - Disposable Products | — | $10,285,000 | $7,589,000 | — | — | — |
| Neurosurgery Navigation and Therapy - Services | — | $0 | $931,000 | — | — | — |
| Product_Functional Neurosurgery Navigation And Therapy Disposable Products | — | — | — | $7,587,000 | $7,696,000 | $6,211,000 |
| Product_Functional Neurosurgery Navigation And Therapy Services | — | — | — | $1,537,000 | $375,000 | $0 |
Key facts
CIK
1285550
CUSIP
18507C103
13F (30d)
108 filings
107 filers
Visit website
Investor relations